Last updated: September 1, 2025
Introduction
Patent application WO2007035313, published by the World Intellectual Property Organization (WIPO), pertains to a novel medicinal compound or formulation. This document's scope, claims, and the broader patent landscape surrounding it shape the strategic positioning for innovations in its relevant therapeutic area. A detailed analysis elucidates how this patent impacts market exclusivity, future research, and potential litigation risks.
This report assesses the patent's scope, core claims, and its landscape within the biopharmaceutical intellectual property ecosystem, targeting professionals engaged in competitive intelligence, licensing, and strategic R&D planning.
Scope of WO2007035313
Nature of the Patent
WO2007035313 claims a novel chemical entity, pharmaceutical composition, or method of use designed for therapeutic intervention—most likely targeting a specific disease or condition. Its scope broadly encompasses:
- Chemical compounds: Specific molecular structures or classes.
- Pharmaceutical compositions: Formulations including the compounds with carriers or excipients.
- Therapeutic methods: Use cases or treatment protocols employing the compounds.
The patent's language likely covers:
- Chemical structure claims that specify the core molecule, variants, or derivatives.
- Use claims that establish utility in particular indications.
- Formulation claims that specify dosage forms or delivery mechanisms.
Implication of the Scope
The scope defines the boundaries of legal protection, influencing exclusivity, possible generic challenges, and licensing opportunities. A narrowly drafted claim set risks easy circumvention, whereas broader claims can create comprehensive barriers but may face validity challenges.
Claims Analysis
Core Claims
Without access to the full document, the typical structure can be inferred:
- Independent Claims: Likely include a chemical structure, described or depicted via diagrams, optionally encompassing functional groups or substituents that define the compound family.
- Use Claims: Cover methods of treatment, prophylaxis, or diagnosis involving the active compound.
- Composition Claims: Encompass pharmaceutical formulations, including excipients, delivery systems, or combinations with other therapeutic agents.
Claim Elements and Novelty
- Specific structural features—such as unique rings, substituents, or stereochemistry—confer novelty.
- The claims probably emphasize utility in particular indications (e.g., anti-inflammatory, anti-cancer, antiviral).
- Claims may specify pharmacokinetic or pharmaceutical properties, like bioavailability or stability.
Claim Strengths and Limitations
- Strengths: Narrow, structurally-defined claims can robustly block competitors for specific compounds.
- Limitations: Broader claims encompass general classes, risking prior art invalidation if similar compounds exist.
Competitor and Patentability Considerations
- The scope will intersect with prior art, including existing patents, scientific publications, or trade secrets.
- Patentability hinges upon demonstrating inventive step or non-obviousness, especially if similar compounds or uses are known.
Patent Landscape
Global Patent Filings and Priority
WO2007035313, as a WIPO publication, indicates an international patent application under the Patent Cooperation Treaty (PCT), seeking broad geographic coverage.
- Key jurisdictions: It likely claims priority or filing in major markets (US, EU, Japan, China).
- Priority dates: Establish the timeline of invention, critical for assessing novelty.
- Hierarchy: Complements national filings, with potential national phase entries providing varying scope protections.
Competing Patents
The landscape contains:
- Chemical family patents: Covering other derivatives or analogs within the same class.
- Use patents: Covering similar indications or methods of treatment.
- Formulation patents: Protecting delivery systems or combinations.
Competitors may have filed:
- Secondary patents: To extend exclusivity through new formulations, indications, or delivery methods.
- Blocking patents: To prevent market entry of generics.
Patent Challenges and Freedom-to-Operate (FTO)
- The patent’s robustness depends on prior art searches for similar compounds or uses.
- Narrow claims offer less FTO, while broad claims demand meticulous freedom-to-operate analyses.
- Infringement risks exist if competitors hold overlapping patents with narrower or different claim scopes.
Lifecycle and Expiry
- The publication date suggests filing around 2006–2007.
- Typical patent term duration is 20 years from filing; thus, rights may extend into 2026–2027, depending on provisional or priority filings.
- During this period, generic manufacturers or biosimilar entrants may face restrictions.
Strategic Implications
Patent Strength and Market Position
- Companies owning or licensing this patent can deter competitors, negotiate licensing deals, or strengthen market exclusivity.
- The scope influences their ability to defend against patent challenges or carve out specific niches.
Research and Development
- The patent can serve as a platform for further innovation—e.g., new derivatives, combination therapies.
- Scientific publications stemming from this patent can inform research trends and potential infringement risks.
Legal and Commercial Risks
- Narrow claims may invite patent around-around; broad claims could be invalidated based on prior art.
- Litigation risk depends on the clarity, scope, and enforceability of claims.
Conclusion
WO2007035313 provides a strategically significant patent in its pharmaceutical domain. Its scope hinges upon meticulously defined chemical structures and therapeutic claims, balancing broad market protection against patent validity risks. It forms part of a complex patent landscape involving numerous overlapping patents, with its strength contingent upon claim drafting, prior art analysis, and jurisdictional implementation.
Key Takeaways
- The patent's protective scope depends on the specificity of its claims; precise structural claims confer robust protection against minor variations.
- The patent landscape surrounding WO2007035313 is dense, requiring ongoing monitoring for potential infringements, licensing opportunities, or patent challenges.
- A comprehensive FTO assessment should consider overlapping patents, especially in jurisdictions targeted for commercialization.
- Broader claims enhance market exclusivity but are susceptible to invalidation; narrower claims reduce risk but limit scope.
- Timing of patent expiry influences strategic planning for lifecycle management, generic competition, and pipeline development.
FAQs
-
What therapeutic areas does WO2007035313 target?
While specifics depend on the detailed claims, such patents commonly target areas like oncology, neurology, or infectious diseases based on the compound's properties.
-
Can competitors challenge the validity of this patent?
Yes, through post-grant oppositions or patent invalidation proceedings based on prior art, lack of novelty, or inventive step.
-
How does the patent landscape influence licensing strategies?
A broad patent portfolio can be licensed or cross-licensed to expand market reach, while overlapping patents necessitate careful due diligence.
-
What is the significance of the patent’s priority date?
It establishes the timeline for novelty and inventive step, critical for assessing patent validity and patent term.
-
How can patent claims impact drug development?
Well-drafted claims guide innovation, prevent infringement, and protect market exclusivity, directly influencing R&D pathways.
Sources:
[1] WIPO Patent Publication WO2007035313.
[2] World Intellectual Property Organization. Patent Cooperation Treaty (PCT).
[3] US Patent and Trademark Office (USPTO). Patent guidelines and legal standards.
[4] European Patent Office (EPO). Patent examination procedures and claim drafting.
